-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA lifts clinical hold on Arbutus Biopharma's AB-101

PUBT·10/22/2026 11:31:19
Listen to the news
FDA lifts clinical hold on Arbutus Biopharma's AB-101
  • FDA lifted the clinical hold on Arbutus Biopharma's AB-101 investigational new drug application, allowing further US clinical development.
  • The company is evaluating next steps for the oral PD-L1 inhibitor, which completed a Phase 1a/1b trial.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arbutus Biopharma Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220730PRIMZONEFULLFEED9850814) on October 22, 2026, and is solely responsible for the information contained therein.